Outer Biosciences couples machine learning with living human skin

Outer Biosciences described YUNA, a discovery platform combining automated assays, machine learning and full-thickness donated human skin that the company says remains viable for four weeks. Its closed-loop workflow predicts candidates, tests them in tissue and returns the results to the models.

Why it matters: The platform illustrates a shift from public-data-only biotech models towards proprietary, experimentally generated human-tissue data and iterative wet-lab validation.

Business/technical/strategic impact: Pharma and cosmetics partners should demand protocol transparency, donor diversity, blinded replication, safety studies and clinical evidence. Throughput, candidate cadence and commercial-performance claims remain company-reported and are not peer-reviewed outcomes.